# First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

> **NCT00251186** · PHASE2 · TERMINATED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 18 (—)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Capecitabine and Cetuximab

## Key facts

- **NCT ID:** NCT00251186
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 18 (—)
- **Why stopped:** Funding unavailable
- **Last updated:** 2010-01-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00251186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00251186, "First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00251186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*